Other OTC - Delayed Quote USD

VentriPoint Diagnostics Ltd. (VPTDF)

0.1599 -0.0077 (-4.59%)
At close: April 24 at 3:56 PM EDT
Loading Chart for VPTDF
DELL
  • Previous Close 0.1676
  • Open 0.1710
  • Bid --
  • Ask --
  • Day's Range 0.1556 - 0.1710
  • 52 Week Range 0.0918 - 0.2687
  • Volume 4,790
  • Avg. Volume 48,841
  • Market Cap (intraday) 25.076M
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 2, 2024 - May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

www.ventripoint.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VPTDF

Performance Overview: VPTDF

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VPTDF
29.93%
S&P/TSX Composite index
4.37%

1-Year Return

VPTDF
17.57%
S&P/TSX Composite index
5.70%

3-Year Return

VPTDF
63.05%
S&P/TSX Composite index
14.51%

5-Year Return

VPTDF
80.88%
S&P/TSX Composite index
31.22%

Compare To: VPTDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VPTDF

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    24.10M

  • Enterprise Value

    22.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    957.21

  • Price/Book (mrq)

    26.15

  • Enterprise Value/Revenue

    633.44

  • Enterprise Value/EBITDA

    -4.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -63.46%

  • Return on Equity (ttm)

    -141.63%

  • Revenue (ttm)

    35.89k

  • Net Income Avi to Common (ttm)

    -4.74M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    32.61%

  • Levered Free Cash Flow (ttm)

    -2.38M

Company Insights: VPTDF

People Also Watch